Your browser doesn't support javascript.
loading
8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study).
Boerekamps, Anne; Vanwolleghem, Thomas; van der Valk, Marc; van den Berk, Guido E; van Kasteren, Marjo; Posthouwer, Dirk; Dofferhoff, Anthonius S M; van Hoek, Bart; Ramsoekh, Dewkoemar; Koopsen, Jelle; Schinkel, Janke; Florence, Eric; Arends, Joop E; Rijnders, Bart J.
Afiliación
  • Boerekamps A; Department of Internal Medicine and Infectious Diseases, Erasmus MC, Rotterdam, the Netherlands.
  • Vanwolleghem T; Department of Gastroenterology and Hepatology, University Hospital Antwerp, Antwerp, Belgium; Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, the Netherlands.
  • van der Valk M; Division of Infectious Diseases, Amsterdam Infection and Immunity Institute, Academic Medical Center, Amsterdam, the Netherlands.
  • van den Berk GE; Department of Internal Medicine and Infectious Diseases, OLVG, Amsterdam, the Netherlands.
  • van Kasteren M; Department of Internal Medicine and Infectious Diseases, Elisabeth-TweeSteden Ziekenhuis, Tilburg, the Netherlands.
  • Posthouwer D; Department of Internal Medicine and Medical Microbiology, Maastricht Universitair Medisch Centrum+, Maastricht, the Netherlands.
  • Dofferhoff ASM; Department of Internal Medicine and Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
  • van Hoek B; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.
  • Ramsoekh D; Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, the Netherlands.
  • Koopsen J; Department of Medical Microbiology, Section of Clinical Virology, Academic Medical Center, Amsterdam, the Netherlands.
  • Schinkel J; Department of Medical Microbiology, Section of Clinical Virology, Academic Medical Center, Amsterdam, the Netherlands.
  • Florence E; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
  • Arends JE; Department of Internal Medicine and Infectious Diseases, Universitair Medisch Centrum Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Rijnders BJ; Department of Internal Medicine and Infectious Diseases, Erasmus MC, Rotterdam, the Netherlands. Electronic address: bartrijnders@me.com.
J Hepatol ; 70(3): 554-557, 2019 03.
Article en En | MEDLINE | ID: mdl-30527953
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Uridina Monofosfato / Bencimidazoles / ARN Viral / Monitoreo de Drogas / Hepacivirus / Hepatitis C Crónica / Fluorenos / Duración de la Terapia Límite: Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Uridina Monofosfato / Bencimidazoles / ARN Viral / Monitoreo de Drogas / Hepacivirus / Hepatitis C Crónica / Fluorenos / Duración de la Terapia Límite: Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos